Sfoglia per AUTORE
MILESI L
Collezione ASL Torino 4
Items : 2
First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Nov;33(11):1179-1185. doi: 10.1016/j.annonc.2022.07.011. Epub 2022 Aug 2.
2022
ASL Torino 4
AOU San Luigi di Orbassano
ASL Torino 4
AOU San Luigi di Orbassano
Rizzo M; Spina F; Milesi L; De Vivo R; Masini C; Merler S; Ermacora P; Verri E; Galli L; Carella C; Santini D; Buti S; Caserta C; Buttigliero C; Battelli N; Ciccarese C; Brunelli M; Iacovelli R; Sperduti I; Fornarini G; Tortora G;
First line avelumab in PD-L1+ve metastatic or locally advanced urothelial cancer (aUC) patients unfit for cisplatin (cis): The ARIES trial in Journal of Clinical Oncology
2022
ASL Torino 4
ASL Torino 4
Sperduti I; Fornarini G; Masini C; Aprile G; Milesi L; Spina F; Rizzo M; Verri E; Ermacora P; Milella M; Buti S; Santini D; Naglieri E; Galli L; Battelli N; Buttigliero C; Caserta C; Ciccarese C; Brunelli M; Iacovelli R;